CDKN1A and neoplasm: In the absence of pRB, the cyclin-dependent kinase inhibitor p21Cip1 is upregulated; however, the overexpression of miR-17~92 caused by pRB-deficiency counteracts the upregulation of p21Cip1, leading to tumor formation [105].